The HGF Receptor c-Met Is Overexpressed in Esophageal Adenocarcinoma-Reference-Cited by-同舟云学术

The HGF Receptor c-Met Is Overexpressed in Esophageal Adenocarcinoma

Published:2005-01 Issue:1 Volume:7 Page:75-84
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Herrera Luis J.,El-Hefnawy Talal,Queiroz de Oliveira Pierre E.,Raja Siva,Finkelstein Sydney,Gooding William,Luketich James D.,Godfrey Tony E.,Hughes Steven J.

Publisher

Elsevier BV

Subject

Cancer Research

Reference34 articles.

1. Rising incidence of adenocarcinoma of the esophagus and gastric cardia;Blot;JAMA,1991

2. Continuing climb in rates of esophageal adenocarcinoma: an update;Blot;JAMA,1993

3. Cancer statistics, 2001;Greenlee;CA Cancer J Clin,2001

4. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product;Bottaro;Science,1991

5. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells;Weidner;J Cell Biol,1990

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET‐dysregulated solid tumours;British Journal of Clinical Pharmacology;2022-10-17

2. Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer;Cancer Control;2022-01

3. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy;Acta Pharmaceutica Sinica B;2021-09

4. C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies;Theranostics;2020

5. When Inhibitor MET Biomarker: Postmortem or Initium Novum?;JCO Precision Oncology;2019-12